Showing results (51-60 of 142) with videos related to

Sort By:
Pageof 15
Clinical Pharmacology and Therapeutics|July 1, 1980
Intravenous N-acetylprocainamide disposition kinetics in coronary artery diseaseR E Kates, P Jaillon, D S Rubenson, et al.
Fundamental & Clinical Pharmacology|December 18, 2004
Low levels of lymphocyte MDR1 gene expression during early renal transplantation in patients treated with tacrolimusL Becquemont, M Camus, F Kriaa, et al.
Clinical Pharmacology and Therapeutics|September 1, 1995
Comparison of chloroguanide and mephenytoin for the in vivo assessment of genetically determined CYP2C19 activity in humansC Partovian, E Jacqz-Aigrain, A Keundjian, et al.
Clinical Pharmacology and Therapeutics|May 1, 1992
Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humansC Funck-Brentano, O Bosco, E Jacqz-Aigrain, et al.
British Journal of Clinical Pharmacology|August 1, 1994
Reproducibility of non-invasive measurement and of short-term variability of blood pressure and heart rate in healthy volunteersL Dimier-David, N Billon, D Costagliola, et al.
Journal of Cardiovascular Pharmacology|June 1, 1987
Cardiovascular beta-adrenergic blocking effects of bornaprolol in humans: relation to dose and plasma concentrationG Cheymol, P Jaillon, B Lecoq, et al.
Journal of the American College of Cardiology|June 1, 1996
Persistent transient myocardial ischemia despite beta-adrenergic blockade predicts a higher risk of adverse cardiac events in patients with coronary artery diseaseT Madjlessi-Simon, M Mary-Krause, F Fillette, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 1, 1988
Deferoxamine reduces neutrophil-mediated free radical production during cardiopulmonary bypass in manP Menasché, C Pasquier, S Bellucci, et al.
Pageof 15